U.S., May 28 -- ClinicalTrials.gov registry received information related to the study (NCT06991335) titled 'VC/VS FOR APATHY IN PD' on May 20.
Brief Summary: Apathy is a disabling neuropsychiatric symptom marked by reduced goal-directed behavior, including diminished interest, motivation, emotional expression, and social engagement. Though not formally defined in the DSM-V, apathy is common in several neurological and psychiatric disorders and significantly affects quality of life. In Parkinson's Disease (PD), it affects about 40% of patients and is associated with increased caregiver burden, reduced functional ability, and nearly threefold higher mortality.
PD affects over 680,000 Americans today and is projected to impact more than 1.2 ...